Placement Completed
Chimeric Therapeutics placement
A$4.4m raised
Announced 23 Dec 2025 · ASX: CHM
Advisers
Chimeric Therapeutics
Issuer
Not disclosed
Lead managers
- Joint lead manager
- Issuer
- Chimeric Therapeutics
- Completed
- 31 Dec 2025
- Sector
- Biotech and pharmaceuticals
Similar deals
- Neurizon Therapeutics placement Nov 2026 · A$4.3m · Biotech and pharmaceuticals
- TrivarX placement Oct 2025 · A$4.2m · Biotech and pharmaceuticals
- Recce Pharmaceuticals placement Jun 2026 · A$4m · Biotech and pharmaceuticals
- NeuroScientific Biopharmaceuticals placement Apr 2025 · A$3.5m · Biotech and pharmaceuticals
- Tryptamine Therapeutics placement Nov 2025 · A$6.1m · Biotech and pharmaceuticals
Sources
- 23 Dec 2025 $8.4 M funding to drive CHM CDH17 and resignation of CMO ASX
- 31 Dec 2025 Application for quotation of securities - CHM ASX